Sodium- and Phosphorus-Based Food Additives: Persistent but Surmountable Hurdles in the Management of Nutrition in Chronic Kidney Disease

Advances in Chronic Kidney Disease

Volumn 20, Issue 2, 2013, Pages 150-156

  Gutiérrez, Orlando M ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

CKD; Diet; Nutrition; Phosphorus; Sodium

Indexed keywords

ALBUMIN; FOOD ADDITIVE; PHOSPHORUS; SODIUM;

BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIETARY INTAKE; FOOD PRESERVATION; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MICROALBUMINURIA; NUTRITIONAL REQUIREMENT; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK BENEFIT ANALYSIS; SODIUM INTAKE; SODIUM RESTRICTION;

FOOD ADDITIVES; FOOD INDUSTRY; HUMANS; PHOSPHORUS, DIETARY; RENAL INSUFFICIENCY, CHRONIC; SODIUM CHLORIDE, DIETARY; UNITED STATES;

EID: 84874285782     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2012.10.008     Document Type: Review

References (66)

1. Macgregor G., de Wardener H.E. Salt, Diet and Health: Neptune's Poisoned Chalice: The Origins of High Blood Pressure 1998, Cambridge University Press, Cambridge, UK.
2. Ritz E. Salt-friend or foe?. Nephrol Dial Transplant 2006, 21(8):2052-2056.
3. Shelef L.A., Seiter J. Indirect and Miscellaneous Antimicrobials. Antimicrobials in Food 2005, 573-598. Taylor and Francis, Boca Raton, FL. 3rd ed. P.M. Davidson, J.N. Sofos, B.A. Larry (Eds.).
4. He F.J., Macgregor G.A. Dietary Salt, High Blood Pressure and Other Harmful Effects on Health. Reducing Salt in Foods: Practical Strategies 2007, 18-54. Woodhead, Cambridge, UK. D. Kilcast, F. Angus (Eds.).
5. Breslin P.A., Beauchamp G.K. Salt enhances flavour by suppressing bitterness. Nature 1997, 387(6633):563.
6. Gillette M. Flavor effects of sodium chloride. Food Technol 1985, 39(6):47-52.
7. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988, 297(6644):319-328. Intersalt Cooperative Research Group.
8. Anderson C.A., Appel L.J., Okuda N., et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc 2010, 110(5):736-745.
9. Mattes R.D. The taste for salt in humans. Am J Clin Nutr 1997, 65(2 suppl):692S-697S.
10. Strategies to Reduce sodium Intake in the United States 2010, Committee on Strategies to Reduce Sodium Intake, Institute of Medicine, The National Academies Press, Washington, DC.
11. Blackburn H., Prineas R. Diet and hypertension: anthropology, epidemiology, and public health implications. Prog Biochem Pharmacol 1983, 19:31-79.
12. James W.P., Ralph A., Sanchez-Castillo C.P. The dominance of salt in manufactured food in the sodium intake of affluent societies. Lancet 1987, 1(8530):426-429.
13. Stamler J., Elliott P., Dennis B., et al. INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary). J Hum Hypertens 2003, 17(9):591-608.
14. He F.J., MacGregor G.A. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009, 23(6):363-384.
15. Meneton P., Jeunemaitre X., de Wardener H.E., MacGregor G.A. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005, 85(2):679-715.
16. Aaron K.J., Campbell R.C., Judd S.E., Sanders P.W., Muntner P. Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Clin Nutr 2011, 94(4):1071-1078.
17. Forman J.P., Scheven L., de Jong P.E., Bakker S.J., Curhan G.C., Gansevoort R.T. Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation 2012, 125(25):3108-3116.
18. Cook N.R., Cutler J.A., Obarzanek E., et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007, 334(7599):885-888.
19. He F.J., MacGregor G.A. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002, 16(11):761-770.
20. Forte J.G., Miguel J.M., Miguel M.J., de Padua F., Rose G. Salt and blood pressure: a community trial. J Hum Hypertens 1989, 3(3):179-184.
21. Sacks F.M., Svetkey L.P., Vollmer W.M., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001, 344(1):3-10.
22. Sanders P.W. Vascular consequences of dietary salt intake. Am J Physiol Ren Physiol 2009, 297(2):F237-F243.
23. Roos J.C., Koomans H.A., Dorhout Mees E.J., Delawi I.M. Renal sodium handling in normal humans subjected to low, normal, and extremely high sodium supplies. Am J Physiol 1985, 249(6 Pt 2):F941-F947.
24. Cianciaruso B., Bellizzi V., Minutolo R., et al. Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Nephrol 1996, 7(2):306-313.
25. Koomans H.A., Roos J.C., Dorhout Mees E.J., Delawi I.M. Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake. Hypertension 1985, 7(5):714-721.
26. Krikken J.A., Laverman G.D., Navis G. Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr Opin Nephrol Hypertens 2009, 18(6):531-538.
27. Food Additives Amendment of 1958. Public Law 85-929; 72 Stat 1784.
28. Bernstein A.M., Willett W.C. Trends in 24-h urinary sodium excretion in the United States, 1957-2003: a systematic review. Am J Clin Nutr 2010, 92(5):1172-1180.
29. Sherman R.A., Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol 2009, 4(8):1370-1373.
30. Sherman R.A., Mehta O. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis 2009, 54(1):18-23.
31. Uribarri J., Calvo M.S. Hidden sources of phosphorus in the typical American diet: does it matter in nephrology?. Semin Dial 2003, 16(3):186-188.
32. Uribarri J. Phosphorus additives in food and their effect in dialysis patients. Clin J Am Soc Nephrol 2009, 4(8):1290-1292.
33. Molins R.A. Phosphates in Food 1991, CRC Press, Inc., Boca Raton, FL.
34. Stahl J.L., Ellinger R.H. The Use of Phosphate In the Cereal and Baking Industry. Symposium: Phosphate in Food Processing 1971, 194-212. The Avi Publishing Company, Inc., Westport, CT. J.M. Deman, P. Melnychyn (Eds.).
35. GRAS (Generally Recognized as Safe) Food Ingredients-Phosphates 1972, The Franklin Institute Research Labs, Philadelphia, PA.
36. Murphy-Gutekunst L. Hidden phosphorus in popular beverages. Nephrol Nurs J 2005, 32(4):443-445.
37. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride 1997, The National Academies Press, Washington, DC.
38. US Department of Agriculture, Agricultural Research Service. Nutrient Intakes from Food: Mean Amounts Consumed per Individual, by Race/Ethnicity and Age. What We Eat in America; NHANES 2009-2010. Available at: Accessed November 4, 2012. http://www.ars.usda.gov/ba/bhnrc/fsrg.
39. Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 2007, 20(4):295-301.
40. Bell R.R., Draper H.H., Tzeng D.Y., Shin H.K., Schmidt G.R. Physiological responses of human adults to foods containing phosphate additives. J Nutr 1977, 107(1):42-50.
41. Calvo M.S. Dietary considerations to prevent loss of bone and renal function. Nutrition 2000, 16(7-8):564-566.
42. Oenning L.L., Vogel J., Calvo M.S. Accuracy of methods estimating calcium and phosphorus intake in daily diets. J Am Diet Assoc 1988, 88(9):1076-1080.
43. Benini O., D'Alessandro C., Gianfaldoni D., Cupisti A. Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients. J Ren Nutr 2011, 21(4):303-308.
44. Moe S.M., Zidehsarai M.P., Chambers M.A., et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 2011, 6(2):257-264.
45. Antoniucci D.M., Yamashita T., Portale A.A. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006, 91(8):3144-3149.
46. Burnett S.M., Gunawardene S.C., Bringhurst F.R., Juppner H., Lee H., Finkelstein J.S. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 2006, 21(8):1187-1196.
47. Ferrari S.L., Bonjour J.P., Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 2005, 90(3):1519-1524.
48. Calvo M.S., Kumar R., Heath H. Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods. J Clin Endocrinol Metab 1988, 66(4):823-829.
49. Calvo M.S., Kumar R., Heath H. Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets. J Clin Endocrinol Metab 1990, 70(5):1334-1340.
50. Calvo M.S., Park Y.K. Changing phosphorus content of the U.S. diet: potential for adverse effects on bone. J Nutr 1996, 126(4 suppl):1168S-1180S.
51. Karkkainen M., Lamberg-Allardt C. An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women. J Bone Miner Res 1996, 11(12):1905-1912.
52. Karp H.J., Vaihia K.P., Karkkainen M.U., Niemisto M.J., Lamberg-Allardt C.J. Acute effects of different phosphorus sources on calcium and bone metabolism in young women: a whole-foods approach. Calcif Tissue Int 2007, 80(4):251-258.
53. Kemi V.E., Karkkainen M.U., Lamberg-Allardt C.J. High phosphorus intakes acutely and negatively affect Ca and bone metabolism in a dose-dependent manner in healthy young females. Br J Nutr 2006, 96(3):545-552.
54. Kemi V.E., Rita H.J., Karkkainen M.U., et al. Habitual high phosphorus intakes and foods with phosphate additives negatively affect serum parathyroid hormone concentration: a cross-sectional study on healthy premenopausal women. Public Health Nutr 2009, 12(10):1885-1892.
55. Sullivan C., Sayre S.S., Leon J.B., et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 2009, 301(6):629-635.
56. Specifications for the Identity and Purity of Food Additives and their Toxicological Evaluation: Emulsifiers, Stabilizers, Bleaching and Maturing Agents 1964, Seventh report of the Joint FAO/WHO Expert Committee on Food Additives WHO Technical Report Series, No. 281, World Health Organization, Geneva, Switzerland.
57. Food and Agriculture Organization of the United Nations. Evaluation of the Toxicity of a Number of Antimicrobials and Antioxidants. Sixth report of the Joint FAO/WHO Expert Committee on Food Additives (Food and Agriculture Organization of the United Nations) (World Health Organization). WHO Technical Report Series, No. 228. Geneva, Switzerland: World Health Organization; 1962.
58. Evaluation of the Health Aspects of Phosphates as Food Ingredients Final Report. Bethesda, MD: Federation of American Societies for Experimental Biology, Life Sciences Research Office. NTIS Report No. SCOGS-32;1975. Available at: Accessed November 4, 2012. http://www.ntis.gov/search/product.aspx%3fABBR%BCPB262651.
59. Schoppet M., Shroff R.C., Hofbauer L.C., Shanahan C.M. Exploring the biology of vascular calcification in chronic kidney disease: what's circulating?. Kidney Int 2008, 73(4):384-390.
60. Gutierrez O.M. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis. Clin J Am Soc Nephrol 2010, 5(9):1710-1716.
61. El-Abbadi M.M., Pai A.S., Leaf E.M., et al. Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int 2009, 75(12):1297-1307.
62. Faul C., Amaral A.P., Oskouei B., et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011, 121(11):4393-4408.
63. Mirza M.A., Larsson A., Lind L., Larsson T.E. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 2009, 205(2):385-390.
64. Yilmaz M.I., Sonmez A., Saglam M., et al. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial. Am J Kidney Dis 2012, 59(2):177-185.
65. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000, 26(3):345-348.
66. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate 2005, The National Academies Press, Washington, DC.